Diabetes, Obesity & Metabolism

Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6-Month Claims Database Analysis

By Theresa M. Hunter, Malvika Venkataraman, Donna Mojdami, Karishma Desai

Cohort study of 22,512 peopleInterventions

6 months

The paper

Theresa M. Hunter, Malvika Venkataraman, Donna Mojdami, Karishma Desai

Eli Lilly (United States); Carelon Research Wilmington Delaware USA

Diabetes, Obesity & Metabolism, 10 Aug 2026

doi.org/10.1111/dom.71064 PubMed 42575714

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial